Intelligence Platform
Patents
Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6284778
Methods and compositions for stimulating neurite growth
expired patentUS 6268384
Compounds possessing neuronal activity
expired patentUS 6265380
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
expired patentUS 6258948
Inhibitors of Interleukin-1.beta. converting enzyme
expired patentUS 6225350
Butyrate prodrugs derived from lactic acid
expired patentUS 6204261
Inhibitors of interleukin-1.beta. Converting enzyme inhibitors
expired patentUS 6172086
Methods and compositions for stimulating neurite growth
expired patentUS 6162800
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors
expired patentUS 6162790
Inhibitors of interleukin-1.beta. converting enzyme
expired patentUS 6147080
Inhibitors of p38
expired patentUS 6136787
Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors
expired patentUS 6128582
Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable
expired patentUS 6127372
Sulfonamide inhibitors of aspartyl protease
expired patentUS 6124328
Methods and compositions for stimulating neurite growth
expired patentUS 6121266
Pyridazines as interleukin-1.beta. converting enzyme inhibitors
expired patentUS 6103711
Inhibitors of interleukin-1.beta. converting enzyme
expired patentUS 6054472
Inhibitors of IMPDH enzyme
expired patentUS 6037370
Methods and compositions for stimulating neurite growth
expired patentUS 6025147
Inhibitors of interleukin-1 .beta. converting enzyme
expired patentUS 6011001
Method of protein therapy by orally administering crosslinked protein crystals
expired